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A B S T R A C T
Application of functional imaging techniques to animal models is vital to understand pain mechanisms, but is
often confounded by the need to limit movement artefacts with anaesthesia, and a focus on evoked responses
rather than clinically relevant spontaneous pain and related hyperalgesia. The aim of the present study was to
investigate the potential of manganese-enhanced magnetic resonance imaging (MEMRI) to measure neural
responses during on-going pain that underpins hyperalgesia in pre-clinical models of nociception. As a proof of
concept that MEMRI is sensitive to the neural activity of spontaneous, intermittent behaviour, we studied a
separate positive control group undergoing a voluntary running wheel experiment.
In the pain models, pain behaviour (weight bearing asymmetry and hindpaw withdrawal thresholds (PWTs))
was measured at baseline and following either intra-articular injection of nerve growth factor (NGF, 10 µg/
50 µl; acute pain model, n=4 rats per group), or the chondrocyte toxin monosodium iodoacetate (MIA, 1 mg/
50 µl; chronic model, n=8 rats per group), or control injection. Separate groups of rats underwent a voluntary
wheel running protocol (n=8 rats per group). Rats were administered with paramagnetic ion Mn2+ as soluble
MnCl2 over seven days (subcutaneous osmotic pump) to allow cumulative activity-dependent neural
accumulation in the models of pain, or over a period of running. T1-weighted MR imaging at 7 T was
performed under isoﬂurane anaesthesia using a receive-only rat head coil in combination with a 72 mm volume
coil for excitation.
The pain models resulted in weight bearing asymmetry (NGF: 20.0 ± 5.2%, MIA: 15 ± 3%), and a reduction
in PWT in the MIA model (8.3 ± 1.5 g) on the ﬁnal day of assessment before undergoing MR imaging. Voxel-
wise and region-based analysis of MEMRI data did not identify group diﬀerences in T1 signal. However, MnCl2
accumulation in the VTA, right Ce amygdala, and left cingulate was negatively correlated with pain responses
(greater diﬀerences in weight bearing), similarly MnCl2 accumulation was reduced in the VTA in line with
hyperalgesia (lower PWTs), which suggests reduced regional activation as a result of the intensity and duration
of pain experienced during the 7 days of MnCl2 exposure. Motor cortex T1-weighted signal increase was
associated with the distance ran in the wheel running study, while no between group diﬀerence was seen. Our
data suggest that on-going pain related signal changes identiﬁed using MEMRI oﬀers a new window to study the
neural underpinnings of spontaneous pain in rats.
Introduction
Chronic pain disorders are debilitating, costly to society and have a
complex pathophysiology (Tracey and Bushnell, 2009). Imaging tech-
niques are important tools in the study of chronic pain (Lee and Tracey,
2013) but the vast majority of imaging studies of pain focus on evoked
responses rather than spontaneous pain, but the brain regions acti-
vated by painful stimuli only partially overlap with those attributed to
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spontaneous pain (Parks et al., 2011), with a shift to emotional brain
regions such as the amygdala and putamen (Kulkarni et al., 2007;
Howard et al., 2011; Cottam et al., 2016). Conversely experimental
hyperalgesia induces upregulation of brain responses within known
pain processing areas with signiﬁcantly higher BOLD responses to
cutaneous noxious stimuli in the dorsal anterior cingulate, bilateral
anterior, left posterior insula, right inferior parietal lobule, right middle
frontal gyrus and left striatum, based on a recent meta-analysis of 11
studies (Tanasescu et al., 2016).
Animal models oﬀer a number of beneﬁts to the study of chronic
pain, including the evaluation of novel treatments and diﬀerentiation of
underlying mechanisms across diﬀerent types of pain (Borsook and
Becerra, 2011). The clinical relevance of the models of pain employed,
type of assessments of pain response (evoked versus on-going re-
sponses) and longitudinal testing of the models are fundamental to
optimise translational validity of the ﬁndings (Tappe-Theodor and
Kuner, 2014). Greater emphasis of pre-clinical studies on the neural
mechanisms underlying spontaneous pain may provide targets for
more eﬀective treatment options in chronic pain disorders. Functional
magnetic resonance imaging (fMRI) provides an important snap-shot
of brain regional activity, however commonly images are acquired from
anaesthetised animals which, whilst acceptable for the acquisition of
structural data, can limit the information obtained from functional
scans (Borsook and Becerra, 2011; Martin et al., 2006; Martin, 2014;
Abaei et al., 2016) if not entirely obscure activity (Thompson et al.,
2014). Although imaging in awake animals is feasible, it may introduce
other confounds such as stress (Thompson and Bushnell, 2012). An
alternative fMRI-based approach is to administer an activity-depen-
dent magnetic resonance (MR) contrast agent with a long half-life
whilst the animals are awake to capture waking-state activity when the
animal is anaesthetised during read out. Mn2+ is a paramagnetic ion
usually delivered as MnCl2, which acts as a Ca
2+ analog and has a half-
life of approximately 12 days in cortex (Chuang et al., 2009). MnCl2
enters excitable cells via voltage-, receptor- or non-speciﬁc calcium
channels and can be used for functional contrast related to neural
activity (Silva et al., 2004; Boretius and Frahm, 2011) that is not
dependent on a haemodynamic response. Although early studies using
acute MnCl2 administration had issues with toxicity (Olanow, 2004;
Wolf and Baum, 1983; Silva et al., 2004; Jackson et al., 2011), slower
longer-term administration has overcome this problem (Eschenko
et al., 2010; Hoch et al., 2013; Mok et al., 2012).
Here we have sought to address both the over-reliance on evoked
data in pain studies and the limitations of acquiring imaging data from
anaesthetised animals. We hypothesized that manganese-enhanced
magnetic resonance imaging (MEMRI) could identify regional brain
activity related to ongoing pain behaviour in the rat. To address this
question a short-lasting, versus longer-lasting, model of pain behaviour
was employed. Nerve growth factor (NGF) is a pro-inﬂammatory
molecule that produces a relatively short lasting sensitization and
activation of sensory nerves following subcutaneous or intra-articular
injection into the knee joint (Lewin et al., 2014). The second model
employed is associated with a longer-lasting period of nociceptive
behaviour following the intra-articular injection of the chondrocyte
toxin monosodium iodoacetate (MIA), which replicates aspects of the
joint pathology and pain exhibited by human OA (Guingamp et al.,
1997; Combe et al., 2004). Herein we report the ﬁrst use of MEMRI to
examine regional uptake of MnCl2, and, by inference, activity, in the
brain following a period of short term nociceptive behaviour or versus
sustained nociceptive pain behaviour in separate groups of rats. As a
control, the eﬀects of running on regional uptake of MnCl2 were also
quantiﬁed in a separate group of rats.
Methods
The experiments described were approved by the local University
ethical committee and all procedures were performed and speciﬁcally
licensed following approval by the UK Home Oﬃce and in accordance
with the Animals (Scientiﬁc Procedures) Act 1986 which incorporates
Council Directive 2010/63EU of the European Parliament. Adult male
Sprague Dawley rats (n=32) were used (Charles River, Margate, UK)
and were housed on a reversed 12-h dark/artiﬁcial-light cycle in
conventional cages at a temperature of 21 ± 2 °C and 55% humidity;
food and water were available ad libitum.
Intra-articular injections
Rats were randomly assigned to a treatment group brieﬂy anesthe-
tised with isoﬂurane (2.5–3% in O2) and received either intra-articular
injection through the infra-patellar ligament of the left knee of nerve
growth factor (NGF 10 µg/50 µl in saline; Sigma, Gillingham, UK; dose
based on (Ashraf et al., 2014), n=4), monosodium iodoacetate (MIA;
1 mg /50 µl in saline; Sigma; dose based on (Sagar et al., 2010), n=8),
or saline (50 µl; n=12) using a 30 gauge hypodermic needle. For the
NGF group, a second identical injection of NGF was given three days
after the ﬁrst injection (Fig. 1). Accuracy of injection was conﬁrmed at
the end of the study by the un-blinding of pain behaviour data. All
Fig. 1. Timelines of the acute intra-articular nerve growth factor (A) and chronic intra-
articular monosodium iodoacetate (B) pain models and also the running wheel study (C).
In the NGF model, two intra-articular injections of either saline or NGF were given on
days (d) 0 and 3. In the MIA model, a single intra-articular injection of saline or MIA was
given on d0. Behavioural pain assessments were performed as indicated and comprised
of hindpaw withdrawal thresholds (PWT), weight bearing diﬀerence (WB) and locomo-
tion. In the running wheel study rats had access to a running wheel for 3 h per day for 5
days before imaging. In all three studies the period of MnCl2 (80 mg/kg) administration
by implanted osmotic pump is indicated by gray arrows.
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surgical procedures were performed in a blinded fashion, under sterile
conditions in an animal procedure room away from animal holding
areas. The experimental unit was a single animal.
Behavioural testing
After intra-articular injection, rats were maintained under the same
conditions as during the pre-operative period. The posture and
behaviour of rats was carefully monitored following recovery from
the anaesthesia and throughout the study. Weight gain, changes in
hindlimb weight distribution and mechanical paw withdrawal thresh-
olds (PWTs) were measured by an experimenter blinded to treatment
immediately prior to intra-articular injection (day 0, baseline) and at
regular intervals (days 1, 3 and 4 in the NGF short-lasting pain study in
which a second intra-articular injection of NGF was given on day 3, and
on days 3–17 in the MIA longer-lasting pain study; Fig. 1) until the day
of imaging. Spontaneous locomotion and rearing activity was measured
in the MIA-treated rats on day 17. The tester was blind to the treatment
at the time of testing. Behavioural tests were always performed
between 8 a.m. and noon.
Healthy rats distribute their weight evenly between both paws, and
changes in weight distribution are used as an indicator of discomfort
and associated pain. Weight-distribution through the left (ipsilateral)
and right (contralateral) hindpaw were assessed using an incapacitance
tester (Linton Instrumentation, Diss, UK), as previously described
(Sagar et al., 2014). Three weight bearing measures were taken at each
time point, measures from the left hindpaw were subtracted from right
hindpaw and converted to a percentage change (0% signiﬁes equal
weight distribution while > 0% represents a shift of weight distribution
to the uninjured limb). Mechanical PWTs were assessed using cali-
brated von Frey monoﬁlaments (Semmes-Weinstein monoﬁlaments of
bending forces 1, 1.4, 2, 4, 6, 8, 10, 15 and 26 g; Linton
Instrumentation) applied to the plantar surface of the hind paw in
ascending order of bending force. Each hair was applied three times for
approximately 2–3 s periods or until a withdrawal response was evoked
using established criteria (Chaplan et al., 1994). After a response, the
paw was retested with the monoﬁlaments in descending order until no
response occurred, at which point the monoﬁlaments were again
applied in ascending order until the response could once again be
evoked. The monoﬁlament that evoked this ﬁnal reﬂex was noted as the
PWT.
Spontaneous locomotor and rearing activity was recorded during a
1 h period in an unfamiliar Perspex arena (39 cm × 23.5 cm × 24.5 cm)
using a computerised infra-red activity system (Photobeam Activity
System, San Diego Instruments, San Diego, USA) under dimmed
lighting. Horizontal ambulatory activity was measured as the consecu-
tive interruption of two adjacent lower beams, while the number of
rears was measured by interruption of a separate layer of upper beams.
Cumulative beam-breaks were automatically recorded in 5 min time
bins for the test duration (Watson et al., 2012).
Voluntary wheel running in rats
In an additional group of adult male Sprague Dawley rats wheel
running was used as a positive control based on a similar published
MEMRI study (Eschenko et al., 2010). Following one week of
acclimatisation rats were provided with a running wheel for 3 h
duration for 5 nights. A wheel running system with a diameter of
27 cm with a magnetic detector and a wireless bicycle computer with
anti-interference wireless recorder were synchronised and calibrated
such that one full rotation was set to a distance of 84.7 cm (wheel
circumference = π * diameter).
Following training and habituation of rats to the running wheel
system, rats were assigned to either a running group or non-running
group (n= 8 rats per group). One rat was placed into a cage with a
single running wheel for three hours on ﬁve consecutive nights (20:00
to 23:00) before being returned to home cage. Distance ran was
recorded and rats that showed consistent running ( > 200 m per
session) for four or more sessions were selected for the running group.
The non-running group of rats (n=8) were not given access to a
functional running wheel system (apparatus was present but could not
rotate) and therefore the distance these rats ran on the wheel was zero
meters.
Osmotic pump implantation for MnCl2 administration
MnCl2·(H2O)2 (VWR, Lutterworth, UK) was administered chroni-
cally via an osmotic pump (model 2001, 200 µl volume; Alzet,
Cupertino, USA). Implantation of osmotic pumps was performed seven
days before imaging (day −2 in the NGF acute pain study and day 14 in
the MIA chronic pain study; Fig. 1) or, in the case of the wheel running
study, six days before imaging (one day before the commencement of
the running wheel protocol). Rats were brieﬂy anesthetised (3%
isoﬂurane in 1 L/min oxygen and then maintained at 2.5% isoﬂurane).
Once areﬂexic, a strip between the shoulder blades was shaved and
then the skin swabbed with chlorhexidine and 5% lidocaine/prilocaine
cream (EMLA; AstraZeneca, Macclesﬁeld, UK) was applied topically. A
small horizontal incision ( < 2 cm) was made between the shoulders
and an osmotic pump was inserted and the skin sutured. Consistent
with previous studies (Eschenko et al., 2010; Hoch et al., 2013) osmotic
pumps had MR-compatible polyetheretherketone tubing (Alzet) and
were loaded with saline or 80 mg/kg/200 µl MnCl2·(H2O)2 (equivalent
Fig. 2. Pain behaviour was assessed immediately before and 24 h after each intra-
articular injection of NGF (10 µg/50 µl, n=4, red line) or saline (50 µl, n=4, blue line). (A)
There was signiﬁcant weight bearing asymmetry at all time points after the ﬁrst NGF
injection on day 0, compared to injection of saline. Weight bearing asymmetry was
sustained but not further increased following the second injection of NGF on day 3. (B)
There was no change in hindpaw withdrawal thresholds following intra-articular
injection of NGF or saline at either day 0 or 3. Data were analysed using a two-way
ANOVAs (drug × time) and Sidak's multiple comparison post-hoc test; error bars
represent standard error of the mean; *** p < 0.001, **** p < 0.0001.
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to an overall dose of 24 mg/kg Mn2+ or 3.4 mg/kg/day Mn2+; all doses
refer to MnCl2·(H2O)2 unless otherwise stated) in saline and released
at a rate of 1 µl/h (0.4 mg/kg/µl). Osmotic pump action begins when
the unit reaches body temperature; to ensure release immediately upon
implantation, osmotic pumps were placed in a water bath heated to
37 °C the evening before implantation surgery.
MR relaxation rates are related to the local concentration of Mn2+
and, therefore, suﬃcient amounts of MnCl2 are necessary for detectable
MRI contrast (Chuang et al., 2009; Silva and Bock, 2008). The upper
dose of MnCl2 that can be administered is limited due to toxicity and
signal saturation. Toxic eﬀects of Mn2+ are reported at 5.5 mg/kg i.p.
(administered as 20 mg/kg MnCl2·(H2O)4 (Jackson et al., 2011)),
though note that signiﬁcant variation exists according to species and
administration route (Boretius and Frahm, 2011). Signal saturation
has been reported with the administration of 49.9 mg/kg Mn2+ over 11
days (6 × 8.4 mg/kg Mn2+ i.p. every 48 h equivalent to a daily dose of
4.2 mg/kg Mn2+; re-calculated here as Mn2+ but administered as
MnCl2·(H2O)4) (Bock et al., 2008; Silva and Bock, 2008). The dose
used in our study, equivalent to 24 mg/kg Mn2+ over seven days, has
previously been validated by other groups and shown to produce
suﬃciently high local concentrations to generate good MRI contrast,
enabling activity-dependent signal enhancement whilst avoiding Mn2+
toxicity (Eschenko et al., 2010; Hoch et al., 2013).
To ensure that any potential eﬀects of MnCl2 on pain behaviour
were identiﬁed, average pain behaviour measures in the week before
(days 7 and 10) and after (days 14 and 17) osmotic pump implantation
in MIA rats were compared.
MEMRI acquisition and analysis
Imaging was performed on a 30 cm bore, 7 T MR scanner (Bruker
Biospec 70/30) using a Bruker Avance III console (Bruker BioSpin,
Ettlingen, Germany). Anaesthesia was induced with 3–5% isoﬂurane in
oxygen and maintained at 1–2%; respiration was monitored to provide
an index of anaesthetic depth (Model 1032, SA Instruments, Stony
Brook, USA) and body temperature was maintained at 37 ± 1 °C via a
water-pump system connected to tubing embedded in the base of the
rat cradle. Saline was constantly infused via a subcutaneous line at a
rate of 2 ml/h. Data were recorded using a receive-only rat head coil in
combination with a 72 mm volume coil for excitation. Coronal T2 scans
(rapid acquisition with refocused echoes, RARE) were acquired with
the following parameters: eﬀective TE = 28.5 ms, echo train length = 8,
repetition time (TR) = 8055 ms, number of signal averages = 4, ﬁeld of
view (FOV) = 48 × 48×32 mm, matrix = 256 × 256×64, voxel size =
0.1875 × 0.1875 × 0.5 mm. Relative uptake of Mn2+ was measured
with a modiﬁed driven equilibrium Fourier transform (MDEFT;
(Canals et al., 2008)) T1 scan with parameters identical to those
reported in Eschenko et al. (Eschenko et al., 2010), optimised in that
study for the contrast-to-noise ratio in the thalamus after Mn2+
accumulation following injection in the motor cortex: TE = 4 ms, TR
Fig. 3. Representative MDEFT images and indication of ROIs used to calculate average signal intensities. Following administration of MnCl2 there was a heterogeneous signal
distribution as shown in horizontal (A), sagittal (B) and coronal (C) planes of the rat brain. The selected ROIs are shown overlaid on MDEFT scans in coronal slices (posterior to anterior,
D-I respectively). PAG: peri-aqueductal gray, VTA: ventral tegmental area, Hipp: hippocampus, VPL: ventroposterior lateral nucleus of the thalamus, Ent ctx: entorhinal cortex, S2:
secondary somatosensory cortex, Ins: insula, Amyg: amygdala, S1HL: hindlimb primary somatosensory cortex, Cing: cingulate, NAcc: nucleus accumbens. Distances indicated are
measurements from bregma according to the Paxinos & Watson rat brain atlas (Paxinos and Watson, 1998).
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= 22 ms, ﬂip angle = 20°, inversion delay = 1000 ms. Coronal images
were obtained with a FOV of 48 × 48×32 mm and a matrix size of 192 ×
192×64, voxel size = 0.25 × 0.25 × 0.5 mm.
Two analyses of MEMRI data were performed: a region-based
analysis using thirteen ROIs modiﬁed from the freely available Schwarz
atlas (Schwarz et al., 2006), and a voxel-wise comparison. This
combination of analyses has successfully been applied to similar
MEMRI data sets by other groups (Bissig and Berkowitz, 2009; Hoch
et al., 2013). Images were manually aligned to the Schwarz atlas and
interpolated to identical dimensions (i.e. 96 × 96×30 voxels, 0.2 × 0.2 ×
0.8 mm). MDEFT images in the coronal plane were rotated to the
vertical and orthogonal to the horizontal planes using midline struc-
tures (e.g. third ventricle and the contact point between left and right
retrospenial cortex) and sagittal slices rotated such that the dorsal
surface of the inferior colliculus and olfactory bulbs were level (all
rotations performed using ImageJ; v1.47, National Institute of Health,
Bethesda, U.S.A.). Brains were roughly aligned to a standard brain size
using the co-ordinates of dorsal, ventral and lateral extremes in two
speciﬁc coronal slices using custom-written Matlab scripts (v2012 A;
Natick, U.S.A.). Slices used to resize brains were those that most closely
corresponded to atlas images (Paxinos and Watson, 1998) at −3.6 mm
(identiﬁed by the anterior-most appearance of the lateral ventricles)
and +1.6 mm (the anterior-most formation of the corpus callosum, i.e.
the genu) with respect to bregma. Images were then trimmed and
interpolated between slices that corresponded to −8.72 mm (opening
of the fourth ventricle) and +3.2 mm (separation of the olfactory
ventricle and forceps minor of the corpus callosum). The broad signal
intensity gradient was corrected using the bias ﬁeld correction utility in
SPM8 (Wellcome Trust Centre for Neuroimaging, University College
London, London, UK) using medium bias regularisation, 40 mm
FWHM Gaussian smoothness (dimensions of voxels were increased
by an order of magnitude in SPM functions). In order to ensure
standardised ROIs were applicable to all individual brains, an average
brain was produced from all brains and all individual brains aligned to
the average brain using the Normalisation function within SPM8
(restricted to slices between −6.7 and 2.2 mm with respect to bregma).
As is customary in MEMRI analyses, each brain underwent tissue
normalisation to the average signal of a region which was not expected
to be activated in the two pain models (Eschenko et al., 2010; Yu et al.,
2005; Bissig and Berkowitz, 2009); in the current study, signal was
normalised to bilateral visual cortex. In the region-based analysis,
average signal intensities were extracted for the following ROIs that
have previously been implicated in acute and/or chronic pain (Mao
et al., 1993): hindlimb primary somatosensory cortex (S1HL, contral-
ateral to injection), secondary somatosensory cortex (S2), ventropos-
terior lateral nucleus of the thalamus (VPL; the hindlimb somatosen-
sory area of the thalamus, contralateral to injection), anterior and
posterior insula, cingulate (rat areas cg1 and cg2 encompassing areas
equivalent to human anterior cingulate), nucleus accumbens (NAcc),
entorhinal cortex, hippocampus (Hipp), peri-aqueductal gray (PAG)
Fig. 4. Results of MEMRI scans in the acute pain, nerve growth factor (NGF) study. Average signal intensities for each ROI following two intra-articular injections of either NGF (10 µg/
50 µl, n=4) or saline (50 µl, n=4). S1HL: hindlimb primary somatosensory cortex, S2: secondary somatosensory cortex, VPL: ventroposterior lateral nucleus of the thalamus, Ant Ins:
anterior insula, Post Ins: posterior insula, Cing: cingulate, NAcc: nucleus accumbens, Ent ctx: entorhinal cortex, Hipp: hippocampus, PAG: peri-aqueductal gray, VTA: ventral-tegmental
area, Amyg BL: basolateral amygdala, Amyg Ce: central nucleus of the amygdala. Average coronal brain images of all saline-injected (B-D, n=4) and NGF-injected animals (E-G, n=4) are
shown. Images correspond to −3.3 mm (B, E), −1.8 mm (C, F), and +1.2 mm (D, G) with respect to bregma based on the Paxinos & Watson rat brain atlas (Paxinos and Watson, 1998).
Colour bar represents normalised signal intensity.
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and ventral-tegmental area (VTA), and the basolateral (BL) and central
nucleus (Ce) of the amygdala. For the running wheel study, a combined
sensorimotor ROI comprising the VPL and sensorimotor cortex
(primary and secondary motor cortex, and hindlimb and forelimb
primary somatosensory cortex) was used.
Statistical analysis
Behavioural data (PWT, weight bearing, locomotor activity and
rearing) were analysed with repeated measures two-way ANOVAs
(drug x time) while any eﬀect of MnCl2 on pain behaviour measures
were analysed with a paired t-test for weight bearing data and a non-
parametric Wilcoxon matched-pairs signed rank test for PWT data.
Region-based MEMRI data in the NGF and MIA pain model studies
were analysed with ordinary two-way ANOVAs (drug x region) followed
by Sidak's multiple comparison post-hoc tests. In the voxel-wise
MEMRI analysis, statistical maps were generated in SPM8 using an
unpaired t-test design between pain model and control brains with a p
value threshold of 0.05 (family-wise error, FWE) with a minimum
threshold cluster size of k=5. This was constrained to search only
within the ROIs listed above by using a combined, binarised mask of all
ROIs. Linear regression was performed on PWT or WB and MEMRI
ROI intensities using animals from both pain models combined. We
also ran a voxelwise regression analysis to identify whether behavioural
indices of ongoing pain and hyperalgesia (WB scores and PWT
respectively) were locally associated with the extent of MEMRI signal
enhancement across both pain models. This analysis was constrained
to within the pain processing areas using the binarised combined ROI
mask from the group analysis and a FWE-corrected threshold of p <
0.05, k > 5. MEMRI data in the running wheel study (i.e. average
intensity from a single sensorimotor ROI) was analysed with an
unpaired t-test. A linear regression was performed in the wheel
running study between the total running distance and MEMRI ROI
intensity from the sensorimotor ROI. Data points were removed from a
group and excluded from analysis if greater than > 2 standard
deviations from the mean (considered a statistical outlier). With
exception of the voxel-wise analysis, all statistical analyses were
performed in Prism (v6.05; Graphpad, La Jolla, USA). All data are
given as mean ± standard error of the mean.
Results
NGF-injected rats: Pain behaviour
Intra-articular injection of NGF produced a shift in weight dis-
tribution to the uninjured limb which was signiﬁcantly diﬀerent to
saline-injected rats on all days tested post-injection (Fig. 2A; signiﬁcant
interaction between drug and time, F3,18 = 13.59, p < 0.0001). Average
weight distribution on the ﬁnal day of behavioural assessment before
imaging (day 4) for saline and NGF-injected rats was −1.5 ± 1.2% and
20.0 ± 5.2%, respectively. NGF-injected rats did not exhibit a
signiﬁcant diﬀerence in PWTs, compared to saline-injected rats
(Fig. 2B).
NGF-injected rats: MEMRI
All acquired brain images exhibited regional heterogeneity in signal
distribution typical of MnCl2 administration; high signal intensities
Fig. 5. Pain behaviour was measured immediately before and up to 17 days after intra-articular injection of MIA (1 mg/50 µl, n=8) or saline (50 µl, n=8). (A) There was a signiﬁcant
weight bearing asymmetry at all time points after injection of MIA compared to injection of saline. (B) Hindpaw withdrawal thresholds were signiﬁcantly lowered at all time points
following MIA injection, compared to saline. Locomotor activity was measured 17 days after intra-articular injection of MIA or saline, 3 days after commencement of MnCl2
administration via osmotic pump. Activity counts (C; two consecutive beam breaks) and rearing (D; single interruption of upper beam breaks) was measured in 5 min bins. There was no
diﬀerence in locomotor activity between rats which received intra-articular injection of MIA versus saline. All data were analysed using two-way ANOVAs (drug x time) and Sidak's
multiple comparison post-hoc test; error bars represent standard error of the mean; *** p < 0.001, **** p < 0.0001.
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were present in inferior colliculus, hippocampal dentate gyrus/cornu
ammonis 3 (CA3), pituitary gland, and lateral habenula (Fig. 3A–C).
Fig. 3D–I illustrates the ROIs from which average signal intensity was
extracted (several ROIs extend over several slices). Following two intra-
articular injections of either saline or NGF in the ﬁve days before
scanning, there were no diﬀerences in signal intensity between saline-
and NGF-treated rats in any of the structures examined (no interaction
between drug and region, F12,78 = 1.31, p = 0.23; Fig. 4A). Three slices
are shown from saline- (Fig. 4B–D) and NGF-injected rats (Fig. 4E–G)
that indicate average signal intensities. Across brain regions there were
marked diﬀerences in signal intensities (signiﬁcant eﬀect of region,
F12,78 = 52.74, p < 0.0001); the Ce amygdala and hippocampus
exhibited the largest and smallest signals, respectively (average of
saline-treated animals for the Ce amygdala and hippocampus was:
1.127 ± 0.017 and 0.966 ± 0.007; average of NGF-treated animals
was 1.103 ± 0.004 and 0.956 ± 0.005). The voxel-wise analysis
performed between the two groups failed to detect any diﬀerence
between voxel intensities (using a threshold of p < 0.05).
MIA-injected rats: Behaviour
Consistent with previous studies, intra-articular injection of MIA
produced a shift in weight distribution to the uninjured limb which was
signiﬁcantly diﬀerent to saline-injected rats on all days tested post-
injection (Fig. 5A; signiﬁcant interaction between drug and time, F5,70
= 10.95, p < 0.0001). Average weight distribution on the ﬁnal day
before imaging (day 17) for saline and MIA-injected rats was 0.1 ±
0.6% and 15 ± 3%, respectively. MIA-injected rats also exhibited a
signiﬁcant decrease in PWTs compared to saline-injected rats (Fig. 5B;
signiﬁcant interaction between drug and time, F5,70 = 7.36, p <
0.0001). Average PWT on the ﬁnal day before imaging (day 17) for
saline and MIA-injected rats were 24.6 ± 1.4 g and 8.3 ± 1.5 g,
respectively. Any potential eﬀects of MnCl2 administration on loco-
motor activity, which would confound pain behaviour in the MIA
group, were assessed by the measurement of spontaneous horizontal
and vertical (rearing) activity on day 17. The proﬁle of locomotor
activity of MIA and saline-inject rats receiving MnCl2 administration
was comparable between the two groups (Figs. 5C and D). Paired
analysis (Wilcoxon t-test), conﬁrmed that pain behaviour remained
stable between the days before (days 7 and 10) and after (days 14 and
17) surgery to implant the osmotic pump and the commencement of
MnCl2 administration (Figs. 6A, B).
MIA-injected rats: MEMRI
Scans took place 21 days following intra-articular injection of either
saline or MIA at a time when diﬀerences in pain behaviour were robust
and stable. There were no diﬀerences in signal intensity between
saline- and MIA-treated rats in any of the ROIs (no interaction between
drug and region, F12,182 = 0.465, p = 0.93; Fig. 7A). Three slices are
shown from saline- (Fig. 7B–D) and MIA-injected rats (Fig. 7E–G) that
indicate average signal intensities. As in the scans of NGF-treated rats,
signal intensities diﬀered between ROIs (signiﬁcant eﬀect of region,
F12,182 = 134.1, p < 0.0001) with the Ce amygdala and hippocampus
exhibiting the largest and smallest signals, respectively (average of
saline-treated animals for the Ce amygdala and hippocampus was:
1.118 ± 0.007 and 0.970 ± 0.004; average of MIA-treated animals
was 1.125 ± 0.008 and 0.975 ± 0.007). The voxel-wise analysis also
failed to detect any group diﬀerence between voxel intensities (using a
threshold of p < 0.05).
Correlations of pain behaviour and MEMRI signal intensity
To further explore any potential relationships between pain beha-
viour and MnCl2 accumulation, data from the NGF and MIA treatment
groups were combined (n=12) and potential correlations investigated
between WB or PWT and regional signal intensity. Behavioural data
used were the average for the periods of maximal pain behaviour (MIA
model: days 14 and 17; NGF model days 1, 3 and 4). Signal intensity,
based on MnCl2 accumulation, was positively correlated with PWTs in
the VTA (R2 = 0.37, F1,9 = 5.23, p < 0.05) and negatively correlated
with weight bearing diﬀerences in the VTA (R2 = 0.43; F1,10 = 7.48, p
< 0.05), the right Ce amygdala (R2 = 0.42, F1,10 = 7.10, p < 0.05), and
the left cingulate (R2 = 0.41, F1,10 = 6.82, p < 0.05) (Fig. 8). No
signiﬁcant associations were identiﬁed using voxelwise regression
analyses in the combined pain model groups.
Voluntary wheel running MEMRI data
Six days following the implantation of the osmotic pump and 9–
16 h after the ﬁnal wheel running session rats underwent imaging.
Average MEMRI signal intensity in the sensorimotor ROI (normalised
to visual cortex) in the control and running groups was 0.969 ± 0.003
and 0.976 ± 0.007, respectively; there was no diﬀerence between the
two groups (t13 = 1.091, p = 0.30, n= 8 per group). However, regression
Fig. 6. Comparison of weight bearing asymmetry (A) and hindpaw withdrawal thresh-
olds (B) before (average of day 7 and 10) and after (average of day 14 and 17) the seven
day period of MnCl2 (80 mg/kg) administration by implanted osmotic pump. Paired data
are indicated with solid black lines. Exposure to MnCl2 did not inﬂuence pain behaviour
in rats that received intra-articular injection of MIA (1 mg/50 µl, n=8) or saline (50 µl,
n=8).
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analysis revealed a signiﬁcant correlation between the average signal
intensity of the sensorimotor ROI and the distance ran by each rat
(Fig. 9; R2 = 0.5946; F1,5 = 7.332; p < 0.05).
Discussion
The aim of the current study was to evaluate the utility of MEMRI
to study spontaneous pain and hyperalgesia in models of acute and
chronic pain of the knee joint. The success of the two models, which
consisted of intra-articular injection of the pro-nociceptive molecule
NGF or the chondrocyte toxin MIA, was conﬁrmed using established
behavioural measures of pain that conﬁrmed the presence of on-going
pain and hyperalgesia, as indicated by changes in WB and PWTs,
respectively. Although comparison between the respective control
groups and the pain models did not reveal any signiﬁcant diﬀerences
in regional uptake of MnCl2, we did reveal a signiﬁcant inverse
relationship between a behavioural index of on-going pain and MnCl2
uptake in the VTA, right amygdala, and left cingulate and a positive
correlation between MnCl2 uptake in the VTA and PWTs.
The rationale for our study was to attempt to address the over-
emphasis of previous preclinical imaging studies on evoked pain
responses in models of either acute or chronic pain, which is often
proposed as one of the reasons that these models have poor transla-
tional validity. Due to the sensitivity of functional activation patterns to
anaesthesia (Thompson et al., 2014) it was also important in the
current study that activity levels acquired from the brain represented
those in the awake state. Given the technical demands and limited
availability of PET scanners, in addition to their low spatial resolution,
we evaluated an MR-based technique of acquiring waking-state brain
activity levels. MEMRI produces activation maps that represent
calcium uptake, which is dependent on the region's neuronal density,
calcium channel density and distance from ventricular space. Over
time, trans-synaptic axonal transport also inﬂuences regional distribu-
tion patterns (Boretius and Frahm, 2011). Slow administration of
MnCl2 is highly suitable for acquiring a surrogate measure of activity
associated with a long-term stimulations such as auditory stimulation
(Yu et al., 2005), visual stimulation (Bissig and Berkowitz, 2009),
nutritional intake (Hoch et al., 2013), ageing (Bissig and Berkowitz,
2014), excitotoxicity (Gobbo et al., 2012), and, theoretically, sponta-
neous pain.
Our study replicated the methodology previously used to demon-
strate increased MEMRI signal in primary motor and somatosensory
cortex following voluntary wheel running (Eschenko et al., 2010).
Consistent with previous studies (Boretius and Frahm, 2011; Lee et al.,
2005) we obtained reliable brain activation maps using MEMRI with a
typical heterogeneity between regions for our diﬀerent experimental
groups. Diﬀerent from a previous MEMRI study showing diﬀerences in
neuropathic and sham rats after a single bolus injection of MnCl2
(Behera et al., 2013), we did not ﬁnd group diﬀerences between pain
models and controls using regional or voxel-based analysis.
Fig. 7. Results of MEMRI scans in the chronic pain, monosodium iodoacetate (MIA) study. (A) Average signal intensities for each ROI 17 days after intra-articular injection of MIA
(1 mg/50 µl, n=8) or saline (50 µl, n=8). Data were normalised to bilateral visual cortex. S1HL: hindlimb primary somatosensory cortex, S2: secondary somatosensory cortex, VPL:
ventroposterior lateral nucleus of the thalamus, Ant Ins: anterior insula, Post Ins: posterior insula, Cing: cingulate, NAcc: nucleus accumbens, Ent ctx: entorhinal cortex, Hipp:
hippocampus, PAG: peri-aqueductal gray, VTA: ventral-tegmental area, Amyg BL: basolateral amygdala, Amyg Ce: central nucleus of the amygdala. Average coronal brain images of all
saline-injected (B-D, n=8) and MIA-injected animals (E-G, n=8) are shown. Images correspond to −3.3 mm (B, E), −1.8 mm (C, F), and +1.2 mm (D, G) with respect to bregma based on
the Paxinos & Watson rat brain atlas (Paxinos and Watson, 1998). Colour bar represents normalised signal intensity.
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Nevertheless, we found moderate correlations of MEMRI signal and
pain behaviour suggesting that our MEMRI experiment had less
sensitivity, only allowing us to detect within group inter-individual
diﬀerences. To conﬁrm this interpretation, we undertook an indepen-
dent experiment repeating the locomotor intervention as in (Eschenko
et al., 2010). We demonstrated a signiﬁcant correlation between MnCl2
uptake in sensorimotor regions (cortex and thalamus) and locomotor
activity over the previous 7 days, but as in our pain study did not detect
between group diﬀerences (running vs. not running rats). However,
whilst we closely replicated the experimental paradigm in Eschenko
et al., 2010, our rats did not run as far over the course of the study
(between 1.3 and 1.7 km versus approximately 4 km total distance),
which likely accounts for this diﬀerence. Indeed, the eﬀect of wheel
running on functional and structural connectivity is well documented,
causing increased grey matter volume in motor and somatosensory
cortex (Sumiyoshi et al., 2014), as well as more global trophic eﬀects
(Kempermann et al., 2010).
Although the sensitivity of MEMRI in absolute neural terms, for
example regional metabolism or spike rate, is unknown, both stimulus
intensity and duration can modulate overall MEMRI signal. Robust
pain behaviour, in particular altered weight bearing (an index of on-
going pain), was evident throughout the period of delivery of MnCl2 in
the present study. Although MEMRI did not detect increases in MnCl2
uptake in brain regions known to be activated by noxious stimuli, we
did however detect signiﬁcant correlations between decreases in MnCl2
uptake in brain regions associated with fear, reward and avoidance and
greater pain behaviour. Herein we report that MnCl2 accumulation in
the VTA, right Ce amygdala, and left cingulate was negatively corre-
lated with pain responses (greater diﬀerences in weight bearing).
Similarly MnCl2 accumulation was reduced in the VTA in line with
Fig. 8. Correlation between mean ROI intensity and paw-withdrawal thresholds (PWT, n=11) and weight bearing (n=12) using combined data from NGF and MIA injection studies.
Data from animals in NGF and MIA groups are shown in red, control animals in blue. A: ventral tegmental area (with PWT data; R2 = 0.37, F1,9 = 5.23, p < 0.05); B: ventral tegmental
area (with weight bearing data; R2 = 0.43, F1,10 = 7.48, p < 0.05); C: right-side central nucleus of the amygdala (with weight bearing data R
2 = 0.42, F1,10 = 7.10, p < 0.05); D: left-side
cingulate (with weight bearing data R2 = 0.41, F1,10 = 6.82, p < 0.05). Note for panel A that lower PWT value indicates more hyperalgesia; for panel B-C higher weight bearing %
indicates higher pain behaviour.
Fig. 9. Correlation between mean ROI intensity and total running distance. Data are
total running distance over the previous ﬁve days against the average signal intensity of
the sensorimotor cortex and VPL thalamus combined (normalised to bilateral visual
cortex). Regression analysis shows that there is a signiﬁcant deviation from 0 (R2 =
0.5946, p < 0.05, n = 7). Data from one rat was a statistical outlier and was excluded
from analysis.
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hyperalgesia (lower PWTs). These data suggest reduced discrete
regional activation as a result of the intensity and duration of pain
experienced during the 7 days of MnCl2 exposure. Our ﬁndings are
consistent with decreased c-Fos activation in the VTA (Narita et al.,
2003) and decreased overall dopamine levels and striatal D2 receptors
in an animal model of chronic pain (Chang et al., 2014; Taylor et al.,
2014). Experimental studies support a role of the VTA in the regulation
of nociceptive responses (Li et al., 2016; Saadé et al., 1997; Sotres-
Bayón et al., 2001; Takeda et al., 2005) and inhibition of dopamine
neurones in the VTA encodes negative emotional signals, predicting
aversive events in the environment (Mileykovskiy and Morales, 2011).
Dopaminergic activation is not likely to occur during chronic pain
states (Baliki and Apkarian, 2015; Vachon-Presseau et al., 2016) and
both animal and human studies suggest that hypodopaminergic tone
associated with chronic pain impairs motivated behaviour (Taylor
et al., 2016).
Asymmetry of amygdala involvement in chronic pain is established,
with right amygdala exhibiting a clearer association (Sadler et al.,
2017). Whilst many studies have found amygdala neurons to increase
activity during chronic pain states, there are many methodological
disparities between diﬀerent experimental paradigms or clinical con-
ditions; and decreases in amygdala activation such as we show in the
present study have been observed (Becerra et al., 1999), especially
when the responses to ranges of pain intensities were measured
(Derbyshire et al., 1997). FMRI studies of conditioned fear circuits in
awake rodents demonstrated activation of the amygdala (Harris et al.,
2015; Brydges et al., 2013), but reduced amygdala activity was
reported in the unpaired group (Harris et al., 2015). Although the role
of anterior cingulate in emotional / aversive aspects of pain processing
is established (Johansen et al., 2001), future MEMRI studies could
investigate further the inﬂuence of on-going pain behaviour and
conditioned place avoidance paradigms. Our demonstration of an
association between a reduction in MnCl2 accumulation in discrete
brain regions and pain behaviour in the models of on-going pain
further reveal the complexities of brain networks altered under these
conditions, and suggests that MEMRI may help to unravel the interplay
between fear, reward and avoidance behaviour in the context of pain.
Comparison of our ﬁndings using MEMRI and our earlier BOLD
imaging study of brain regional responses (Abaei et al., 2016) reveals
marked diﬀerences in the alterations in brain networks following 7
days of on-going pain behaviour versus the response of brain networks
following activation of nociceptive pathways in the same model of pain
under anaesthesia. Noxious stimulation of the MIA knee induced a
signiﬁcantly greater increase in functional connectivity in the medio-
dorsal thalamic nucleus, hippocampus, and globus pallidus, compared
to noxious stimulation of the control knee (Abaei et al., 2016). Other
studies using the MIA model predominantly focused on alterations in
spinal nociceptive responses, such as reﬂex pathways (Kelly et al.,
2015), increased neuronal responses (Sagar et al., 2010) and c-Fos
expression in the spinal cord (Ogbonna et al., 2013), all indicating an
activation of nociceptive pathways.
In conclusion, the moderate regional-speciﬁc correlations of
MEMRI signal and pain behaviour reported herein indicate that in
vivo MEMRI at 7 T is sensitive to cumulative neural eﬀects of pain
behaviour in awake freely moving animals. Further improvements to
MEMRI will arise from recent and ongoing reﬁnement of safe
manganese doses (Gálosi et al., 2017; Poole et al., 2017), as well as
the use of post-mortem scanning (enabling a longer scan time and
therefore resolution) where experimental paradigms allow (Sperry
et al., 2017). These developments, combined with an increase of signal
to noise ratios through use of optimised acquisition hardware (ﬁeld
strength, dedicated coils), may improve the sensitivity of MEMRI to
strengthen future investigations into the neural mechanisms under-
pinning spontaneous pain in rats. The potential key impact will come
from overcoming the reliance of preclinical imaging studies on evoked
pain responses in models of either acute or chronic pain.
Acknowledgements
We would like to thank Arthritis Research UK for funding this work
(grant number 18769), and Clare Spicer (University of Nottingham) for
technical expertise.
References
Abaei, M., et al., 2016. Neural correlates of hyperalgesia in the monosodium iodoacetate
model of osteoarthritis pain. Mol. Pain. 12 (0).
Ashraf, S., et al., 2014. Augmented pain behavioural responses to intra-articular injection
of nerve growth factor in two animal models of osteoarthritis. Ann. Rheum. Dis. 73
(9), 1710–1718.
Baliki, M.N., Apkarian, A.V., 2015. Nociception, pain, negative moods, and behavior
selection. Neuron 87 (3), 474–491.
Becerra, L.R., et al., 1999. Human brain activation under controlled thermal stimulation
and habituation to noxious heat: an fMRI study. Magn. Reson. Med. 41 (5),
1044–1057.
Behera, D., et al., 2013. Bilateral peripheral neural activity observed in vivo following
unilateral nerve injury. Am. J. Nucl. Med. Mol. Imaging 3 (3), 282–290 https://
www.ncbi.nlm.nih.gov/pubmed/23638339.
Bissig, D., Berkowitz, B.A., 2009. Manganese-enhanced MRI of layer-speciﬁc activity in
the visual cortex from awake and free-moving rats. NeuroImage 44 (3), 627–635.
Bissig, D., Berkowitz, B.A., 2014. Testing the calcium hypothesis of aging in the rat
hippocampus in vivo using manganese-enhanced MRI. Neurobiol. Aging 35 (6),
1453–1458.
Bock, N.A., Paiva, F.F., Silva, A.C., 2008. Fractionated manganese-enhanced MRI. NMR
Biomed. 21 (5), 473–478.
Boretius, S., Frahm, J., 2011. Manganese-enhanced magnetic resonance imaging.
Methods Mol. Biol. 771, 531–568.
Borsook, D., Becerra, L., 2011. CNS animal fMRI in pain and analgesia. Neurosci.
Biobehav. Rev. 35 (5), 1125–1143.
Brydges, N.M. et al., 2013. Imaging conditioned fear circuitry using awake rodent fMRI.
Y. Herault, ed. PLoS One, 8(1), e54197.
Canals, S., et al., 2008. Magnetic resonance imaging of cortical connectivity in vivo.
NeuroImage 40 (2), 458–472.
Chang, P.-C., et al., 2014. Role of nucleus accumbens in neuropathic pain: linked multi-
scale evidence in the rat transitioning to neuropathic pain. Pain 155 (6), 1128–1139.
Chaplan, S.R., et al., 1994. Quantitative assessment of tactile allodynia in the rat paw. J.
Neurosci. Methods 53 (1), 55–63.
Chuang, K.-H., Koretsky, A.P., Sotak, C.H., 2009. Temporal changes in the T1 and T2
relaxation rates (DeltaR1 and DeltaR2) in the rat brain are consistent with the tissue-
clearance rates of elemental manganese. Mag. Reson. Med. 61 (6), 1528–1532.
Combe, R., Bramwell, S., Field, M.J., 2004. The monosodium iodoacetate model of
osteoarthritis: a model of chronic nociceptive pain in rats? Neurosci. Lett. 370 (2–3),
236–240.
Cottam, W.J., et al., 2016. Associations of limbic-aﬀective brain activity and severity of
ongoing chronic arthritis pain are explained by trait anxiety. NeuroImage: Clin. 12,
269–276.
Derbyshire, S.W., et al., 1997. Pain processing during three levels of noxious stimulation
produces diﬀerential patterns of central activity. Pain 73 (3), 431–445.
Eschenko, O., et al., 2010. Mapping of functional brain activity in freely behaving rats
during voluntary running using manganese-enhanced MRI: implication for
longitudinal studies. NeuroImage 49 (3), 2544–2555.
Gálosi, R., et al., 2017. Identifying non-toxic doses of manganese for manganese-
enhanced magnetic resonance imaging to map brain areas activated by operant
behavior in trained rats. Magn. Reson. Imaging 37, 122–133.
Gobbo, O.L., et al., 2012. In vivo detection of excitotoxicity by manganese-enhanced
MRI: comparison with physiological stimulation. Mag. Res. Med. 68 (1), 234–240.
Guingamp, C., et al., 1997. Mono-iodoacetate-induced experimental osteoarthritis: a
dose-response study of loss of mobility, morphology, and biochemistry. Arthritis
Rheum. 40 (9), 1670–1679.
Harris, A.P., et al., 2015. Imaging learned fear circuitry in awake mice using fMRI. Eur. J.
Neurosci. 42 (5), 2125–2134.
Hoch, T., et al., 2013. Manganese-enhanced magnetic resonance imaging for mapping of
whole brain activity patterns associated with the intake of snack food in ad libitum
fed rats. PLoS One 8 (2), e55354.
Howard, M.A., et al., 2011. Beyond patient reported pain: perfusion magnetic resonance
imaging demonstrates reproducible cerebral representation of ongoing post-surgical
painPLoS One 6, e17096, B. Baune, ed.
Jackson, S.J., et al., 2011. Manganese-enhanced magnetic resonance imaging (MEMRI)
of rat brain after systemic administration of MnCl₂: hippocampal signal
enhancement without disruption of hippocampus-dependent behavior. Behav. Brain
Res. 216 (1), 293–300.
Johansen, J.P., Fields, H.L., Manning, B.H., 2001. The aﬀective component of pain in
rodents: direct evidence for a contribution of the anterior cingulate cortex. Proc.
Natl. Acad. Sci. USA 98 (14), 8077–8082.
Kelly, S., et al., 2015. Increased function of pronociceptive TRPV1 at the level of the joint
in a rat model of osteoarthritis pain. Ann. Rheum. Dis. 74 (1), 252–259.
Kempermann, G., et al., 2010. Why and how physical activity promotes experience-
induced brain plasticity. Front. Neurosci. 4, 189.
Kulkarni, B., et al., 2007. Arthritic pain is processed in brain areas concerned with
emotions and fear. Arthritis Rheum. 56 (4), 1345–1354.
I.M. Devonshire et al. NeuroImage 157 (2017) 500–510
509
Lee, J.H., et al., 2005. Manganese-enhanced magnetic resonance imaging of mouse brain
after systemic administration of MnCl2: dose-dependent and temporal evolution of
T1 contrast. Mag. Reson. Med. 53 (3), 640–648.
Lee, M.C., Tracey, I., 2013. Imaging pain: a potent means for investigating pain
mechanisms in patients. Br. J. Anaesth. 111 (1), 64–72.
Lewin, G.R., Lechner, S.G., Smith, E.S.J., 2014. Nerve growth factor and nociception:
from experimental embryology to new analgesic therapyHandb. Exp. Pharmacol.
220, 251–282.
Li, A.-L., et al., 2016. Stimulation of the ventral tegmental area increased nociceptive
thresholds and decreased spinal dorsal horn neuronal activity in rat. Exp. Brain Res.
234 (6), 1505–1514.
Mao, J., Mayer, D.J., Price, D.D., 1993. Patterns of increased brain activity indicative of
pain in a rat model of peripheral mononeuropathy. J. Neurosci. 13 (6), 2689–2702.
Martin, C., et al., 2006. Investigating neural-hemodynamic coupling and the
hemodynamic response function in the awake rat. NeuroImage 32 (1), 33–48.
Martin, C., 2014. Contributions and complexities from the use of in vivo animal models
to improve understanding of human neuroimaging signals. Front. Neurosci. 8, 211.
Mileykovskiy, B., Morales, M., 2011. Duration of inhibition of ventral tegmental area
dopamine neurons encodes a level of conditioned fear. J. Neurosci. 31 (20),
7471–7476.
Mok, S.I., Munasinghe, J.P., Young, W.S., 2012. Infusion-based manganese-enhanced
MRI: a new imaging technique to visualize the mouse brain. Brain Struct. Funct. 217
(1), 107–114.
Narita, M., et al., 2003. Change in the expression of c-fos in the rat brain following sciatic
nerve ligation. Neurosci. Lett. 352 (3), 231–233.
Ogbonna, A.C., et al., 2013. Pain-like behaviour and spinal changes in the monosodium
iodoacetate model of osteoarthritis in C57Bl/6 mice. Eur. J. Pain 17 (4), 514–526.
Olanow, C.W., 2004. Manganese-induced parkinsonism and Parkinson's disease. Ann.
N.Y. Acad. Sci. 1012, 209–223.
Parks, E.L., et al., 2011. Brain activity for chronic knee osteoarthritis: dissociating evoked
pain from spontaneous pain. Eur. J. Pain. 15 (8), (843.e1-14).
Paxinos, G., Watson, C., 1998. The Rat Brain in Stereotaxic Coordinates. Academic Press,
San Diego, USA.
Poole, D.S., et al., 2017. Continuous infusion of manganese improves contrast and
reduces side eﬀects in manganese-enhanced magnetic resonance imaging studies.
NeuroImage 147, 1–9.
Saadé, N.E., et al., 1997. Augmentation of nociceptive reﬂexes and chronic
deaﬀerentation pain by chemical lesions of either dopaminergic terminals or
midbrain dopaminergic neurons. Brain Res. 751 (1), 1–12.
Sadler, K.E., et al., 2017. Divergent functions of the left and right central amygdala in
visceral nociception. Pain 158 (4), 747–759.
Sagar, D.R., et al., 2010. Tonic modulation of spinal hyperexcitability by the
endocannabinoid receptor system in a rat model of osteoarthritis pain. Arthritis
Rheum. 62 (12), 3666–3676.
Sagar, D.R., et al., 2014. Osteoprotegerin reduces the development of pain behaviour and
joint pathology in a model of osteoarthritis. Ann. Rheum. Dis. 73 (8), 1558–1565.
Schwarz, A.J., et al., 2006. A stereotaxic MRI template set for the rat brain with tissue
class distribution maps and co-registered anatomical atlas: application to
pharmacological MRI. NeuroImage 32 (2), 538–550.
Silva, A.C., et al., 2004. Manganese-enhanced magnetic resonance imaging (MEMRI):
methodological and practical considerations. NMR Biomed. 17 (8), 532–543.
Silva, A.C., Bock, N.A., 2008. Manganese-enhanced MRI: an exceptional tool in
translational neuroimaging. Schizophr. Bull. 34 (4), 595–604.
Sotres-Bayón, F., et al., 2001. Lesion and electrical stimulation of the ventral tegmental
area modify persistent nociceptive behavior in the rat. Brain Res. 898 (2), 342–349.
Sperry, M.M., et al., 2017. Mapping of pain circuitry in early post-natal development
using manganese-enhanced MRI in rats. Neuroscience 352, 180–189.
Sumiyoshi, A., et al., 2014. Regional gray matter volume increases following 7days of
voluntary wheel running exercise: a longitudinal VBM study in rats. NeuroImage 98,
82–90.
Takeda, R., et al., 2005. Unilateral lesions of mesostriatal dopaminergic pathway alters
the withdrawal response of the rat hindpaw to mechanical stimulation. Neurosci.
Res. 52 (1), 31–36.
Tanasescu, R., et al., 2016. Functional reorganisation in chronic pain and neural
correlates of pain sensitisation: a coordinate based meta-analysis of 266 cutaneous
pain fMRI studies. Neurosci. Biobehav. Rev. 68, 120–133.
Tappe-Theodor, A., Kuner, R., 2014. Studying ongoing and spontaneous pain in rodents–
challenges and opportunities. Eur. J. Neurosci. 39 (11), 1881–1890.
Taylor, A.M.W., et al., 2014. Correlation Between Ventral Striatal Catecholamine Content
and Nociceptive Thresholds in Neuropathic Mice. J. Pain. 15 (8), 878–885.
Taylor, A.M.W., et al., 2016. Mesolimbic dopamine signaling in acute and chronic pain:
implications for motivation, analgesia, and addiction. Pain 157 (6), 1194–1198.
Thompson, S.J., et al., 2014. Metabolic brain activity suggestive of persistent pain in a rat
model of neuropathic pain. NeuroImage 91, 344–352.
Thompson, S.J., Bushnell, M.C., 2012. Rodent functional and anatomical imaging of
pain. Neurosci. Lett. 520 (2), 131–139.
Tracey, I., Bushnell, M.C., 2009. How neuroimaging studies have challenged us to
rethink: is chronic pain a disease? Pain 10 (11), 1113–1120.
Vachon-Presseau, E., et al., 2016. The emotional brain as a predictor and ampliﬁer of
chronic pain. J. Dent. Res. 95 (6), 605–612.
Watson, D.J.G., et al., 2012. Blockade of dopamine D₃ but not D₂ receptors reverses the
novel object discrimination impairment produced by post-weaning social isolation:
implications for schizophrenia and its treatment. Int. J. Neuropsychopharmacol. 15
(4), 471–484.
Wolf, G.L., Baum, L., 1983. Cardiovascular toxicity and tissue proton T1 response to
manganese injection in the dog and rabbit. Am. J. Roentgenol. 141 (1), 193–197.
Yu, X., et al., 2005. In vivo auditory brain mapping in mice with Mn-enhanced MRI. Nat.
Neurosci. 8 (7), 961–968.
I.M. Devonshire et al. NeuroImage 157 (2017) 500–510
510
